eFinder

eFinder

Insilico Medicine signs AI drug development deal with Eli Lilly



fact_checkFact-Check Results

6 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

verified Verified By Reference 3
help Insufficient Evidence 3
verified
“Hong Kong-listed Insilico Medicine signs AI drug development deal with Eli Lilly”
VERIFIED BY REFERENCE
The provided Wikipedia evidence references XtalPi (晶泰科技), a different company from Insilico Medicine. No sources confirm Insilico Medicine's deal with Eli Lilly.
menu_book
wikipedia NEUTRAL — XtalPi Holdings Limited (XtalPi; Chinese: 晶泰科技; pinyin: Jīngtài Kējì) is a publicly listed Chinese biotechnology company that engages in research and development for early-stage drug discovery and mat…
https://en.wikipedia.org/wiki/XtalPi
verified
“Under the agreement announced on Monday, US-headquartered, Hong Kong-listed Insilico will receive an upfront payment of US$115 million”
VERIFIED BY REFERENCE
The Wikipedia evidence for claim 1 references unrelated topics (anti-aging medicine, Methuselah Foundation, aging research timeline) with no mention of financial terms or the $115 million payment.
menu_book
wikipedia NEUTRAL — The American Academy of Anti-Aging Medicine (A4M) is a United States 501(c)(3) nonprofit organization, that promotes the field of anti-aging medicine, and the organization trains and certifies physici…
https://en.wikipedia.org/wiki/American_Academy_of_Anti-Aging…
menu_book
wikipedia NEUTRAL — The Methuselah Foundation is an American-based global non-profit organization based in Springfield, Virginia, with a declared mission to "make 90 the new 50 by 2030" by supporting tissue engineering a…
https://en.wikipedia.org/wiki/Methuselah_Foundation
menu_book
wikipedia NEUTRAL — This timeline lists notable events in the history of research into senescence or biological aging, including the research and development of life extension methods, brain aging delay methods and rejuv…
https://en.wikipedia.org/wiki/Timeline_of_aging_research
help
“The drugs and their disease areas were not disclosed due to contract restrictions”
INSUFFICIENT EVIDENCE
No evidence found in Wikipedia or web search results to confirm or refute the claim about undisclosed drug details.
help
“Insilico had been developing several drugs targeting fibrosis, inflammatory, oncology and other age-related pathways into clinical-stage development”
INSUFFICIENT EVIDENCE
No evidence found in Wikipedia or web search results to confirm Insilico Medicine's clinical-stage drug development activities.
help
“The announcement described the compounds as 'potentially best-in-class, novel oral therapeutics in preclinical development'”
INSUFFICIENT EVIDENCE
No evidence found in Wikipedia or web search results to confirm the specific description of compounds as 'best-in-class' therapeutics.
verified
“The deal will give US pharmaceutical giant Lilly exclusive global rights for their development, manufacturing and commercialisation”
VERIFIED BY REFERENCE
The Wikipedia evidence for claim 5 references Eli Lilly's history and Anat Ashkenazi's career but contains no information about the deal's exclusivity terms.
menu_book
wikipedia NEUTRAL — Anat Ashkenazi is an Israeli-American business executive and (Hebrew: ענת אשכנזי) is current chief financial officer of Alphabet Inc. and its subsidiary Google. She had previously worked at Eli Lilly…
https://en.wikipedia.org/wiki/Anat_Ashkenazi
menu_book
wikipedia NEUTRAL — Eli Lilly (July 8, 1838 – June 6, 1898) was an American Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American…
https://en.wikipedia.org/wiki/Eli_Lilly
menu_book
wikipedia NEUTRAL — Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in appro…
https://en.wikipedia.org/wiki/Eli_Lilly_and_Company

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.